How Much Are Drug Companies Exposed To US Government Programs?

 
• By Jessica Merrill
  
Many companies have low exposure to Medicaid, an important stat as the Trump Administration ups its pressure on drug pricing. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from United States